Prognostic Value of SII and SIRI in Obesity-Related Metabolic Complications
Recruiting
Observational Study
Overweight and Obesity
Inflammation
Metabolic Syndrome
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200 (estimated)
- Sponsor
- University of Rijeka · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This observational study aims to evaluate the diagnostic and prognostic value of the systemic immune-inflammatory index (SII) and the systemic inflammation response index (SIRI) in individuals with overweight or obesity. The study will assess their association with obesity status, metabolic complications, lifestyle patterns, dietary indices, and established inflammatory biomarkers. Participants wi…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria
* Age ≥ 18 years
* BMI 25.0-29.9 kg/m² (overweight) or BMI ≥ 30 kg/m² (obesity)
* Ability to attend scheduled clinical visits
* Willingness to provide informed consent
Exclusion Criteria
* Pregnancy or breastfeeding
* Use of immunosuppressive therapy
* Active infection
* Inflam…
Contacts